We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
-14.48%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
–
AUM
$660M
AUM Growth
-$140M
Cap. Flow
-$5.46M
Cap. Flow %
-0.83%
Top 10 Hldgs %
41.58%
Holding
76
New
5
Increased
11
Reduced
36
Closed
8

Top Buys

1
CRM icon
Salesforce
CRM
+$10.3M
2
PYPL icon
PayPal
PYPL
+$9.99M
3
ILMN icon
Illumina
ILMN
+$3.85M
4
MA icon
Mastercard
MA
+$895K
5
DIS icon
Walt Disney
DIS
+$819K

Top Sells

1
NVRO
NEVRO CORP.
NVRO
+$11.1M
2
COL
Rockwell Collins
COL
+$8.42M
3
TRMB icon
Trimble
TRMB
+$2.18M
4
UPS icon
United Parcel Service
UPS
+$2.04M
5
STT icon
State Street
STT
+$1.84M

Sector Composition

1 Healthcare 45.7%
2 Technology 11.39%
3 Industrials 8.88%
4 Financials 7.73%
5 Consumer Discretionary 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
1
DexCom
DXCM
$30.1B
$34M 5.15%
1,134,016
-12,200
-1% -$387K
MA icon
2
Mastercard
MA
$487B
$30.2M 4.57%
159,850
+4,509
+3% +$895K
ADI icon
3
Analog Devices
ADI
$185B
$28.3M 4.29%
329,656
+786
+0.2% +$68K
CGNX icon
4
Cognex
CGNX
$10.6B
$28.3M 4.29%
731,550
-8,060
-1% -$349K
IDXX icon
5
Idexx Laboratories
IDXX
$45.4B
$26.7M 4.05%
143,565
-100
-0.1% -$20.5K
TIF
6
DELISTED
Tiffany & Co.
TIF
$26.7M 4.04%
331,430
-5,710
-2% -$582K
DHR icon
7
Danaher
DHR
$145B
$25.8M 3.9%
281,826
+2,177
+0.8% +$198K
JNJ icon
8
Johnson & Johnson
JNJ
$602B
$25M 3.79%
193,635
-2,415
-1% -$337K
NEOG icon
9
Neogen
NEOG
$2.25B
$24.9M 3.78%
874,764
-2,070
-0.2% -$64.8K
BF.B icon
10
Brown-Forman Class B
BF.B
$11.9B
$24.6M 3.73%
516,663
-3,211
-0.6% -$153K
ABMD
11
DELISTED
Abiomed Inc
ABMD
$24M 3.64%
73,851
-29
-0% -$10.1K
PODD icon
12
Insulet
PODD
$11.4B
$23.6M 3.58%
297,645
+65
+0% +$5.5K
HON icon
13
Honeywell
HON
$70.6B
$20.5M 3.11%
164,809
-11,047
-6% -$1.51M
RTN
14
DELISTED
Raytheon Company
RTN
$20.4M 3.09%
133,017
-1,092
-0.8% -$196K
SBUX icon
15
Starbucks
SBUX
$124B
$19.7M 2.99%
306,156
-6,325
-2% -$396K
BIIB icon
16
Biogen
BIIB
$30.8B
$19.7M 2.98%
65,333
-1,350
-2% -$431K
INGN icon
17
Inogen
INGN
$180M
$19.2M 2.91%
154,635
+140
+0.1% +$23.1K
ROST icon
18
Ross Stores
ROST
$74.7B
$17.9M 2.71%
215,186
-1,843
-0.8% -$167K
NVO
19
Novo Nordisk
NVO
$228B
$17.6M 2.66%
762,600
-52,750
-6% -$1.17M
HSIC icon
20
Henry Schein
HSIC
$10.1B
$15.4M 2.33%
249,955
-2,805
-1% -$185K
AMGN icon
21
Amgen
AMGN
$201B
$14.6M 2.21%
74,900
-1,025
-1% -$200K
MTD icon
22
Mettler-Toledo International
MTD
$27B
$13.5M 2.05%
23,920
+345
+1% +$200K
ABBV icon
23
AbbVie
ABBV
$449B
$10.3M 1.56%
111,850
-5,100
-4% -$448K
CRM icon
24
Salesforce
CRM
$141B
$10.3M 1.56%
+75,090
New +$10.3M
PYPL icon
25
PayPal
PYPL
$50B
$10.1M 1.53%
+119,945
New +$9.99M
1
2 3

Similar funds

IAS
INR Advisory Services Media, Pennsylvania $786M AUM 2.23% 1-Year Est. Return
ACM
Aviance Capital Management Sarasota, Florida $668M AUM 6.48% 1-Year Est. Return
MFBTD
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return
SGAM
Steinberg Global Asset Management Boca Raton, Florida $639M AUM 11.04% 1-Year Est. Return
AB
AT Bancorp Dubuque, Iowa $823M AUM 0.35% 1-Year Est. Return
NTC
NF Trinity Capital Central, Hong Kong $626M AUM 3.16% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
DSI
Daiwa SB Investments Tokyo, Japan $506M AUM 11% 1-Year Est. Return

Tirschwell & Loewy's Q4 2018 Portfolio in Review

As of Q4 2018, Tirschwell & Loewy held 76 positions worth $660M, down 18% from $800M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Tirschwell & Loewy's Q4 2018 filing shows 5 new, 11 increased, 36 reduced and 8 closed positions. Its largest new stake was Salesforce: 75,090 shares worth $10.3M. The largest sale was NEVRO CORP., an estimated $11.1M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

  • Tirschwell & Loewy's largest Q4 2018 buy was Salesforce: 75,090 shares worth $10.3M.
  • Tirschwell & Loewy added most to Mastercard in Q4 2018, an estimated $895K increase.
  • Tirschwell & Loewy's biggest Q4 2018 reduction was Trimble, cutting an estimated $2.18M.
  • Tirschwell & Loewy fully exited NEVRO CORP. in Q4 2018, selling an estimated $11.1M.
  • Tirschwell & Loewy's ten largest holdings make up 42% of its $660M portfolio in Q4 2018.
  • Tirschwell & Loewy opened 5 new positions and closed 8 in Q4 2018.
  • Tirschwell & Loewy's portfolio value fell 18% quarter-over-quarter to $660M.

Based on Tirschwell & Loewy's 13F filing for Q4 2018, filed 31 Jan 2019.